Rutgers Health/Robert Wood Johnson Medical School
Maternal-Fetal Medicine fellowship · New Brunswick, NJ · Program website
Obstetrics and Gynecology residency here · Other fellowships: Gynecologic Oncology · Reproductive Endocrinology and Infertility
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is Rutgers Health's research in maternal-fetal medicine, which the program shares with other departments and affiliated hospitals.
Maternal-Fetal Medicine at Rutgers Healthshared by every program there, not this program's own
Institution-level: all maternal-fetal medicine publications from Rutgers Health and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
Works per year · * 2026 so far
Maternal-Fetal Medicine research topics at Rutgers Health
Papers in the window; each links to the list on OpenAlex.
Most cited at Rutgers Health since 2024
All maternal-fetal medicine papers there on OpenAlex
- Embracing and implementing the WHO cervical cancer elimination campaign goals: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS on minimum quality care standards for cervical cancer patients in the U.SKatherine Marie Ogden Martino et al. · Gynecologic Oncology · 2025 · PubMed · cited 10
- Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trialRamez Nassef Eskander et al. · Nature Medicine · 2025 · PubMed · cited 97
- Management of Postpartum Preeclampsia and Hypertensive Disorders (MOPP)Emily B. Rosenfeld et al. · JACC Advances · 2025 · PubMed · cited 18
- Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892)Sarah Elizabeth Taylor et al. · Cancer Chemotherapy and Pharmacology · 2024 · PubMed · cited 7
- Overall survival and progression-free survival by PD-L1 status among endometrial cancer patients treated with pembrolizumab plus carboplatin/paclitaxel as compared to carboplatin/paclitaxel plus placebo in the NRG GY018 trialRamez Nassef Eskander et al. · Gynecologic Oncology · 2024 · cited 7
- Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm PreeclampsiaMaya Patel et al. · Obstetrics and Gynecology · 2024 · PubMed · cited 7
- Optimal Timing of Delivery for Pregnant Individuals With Mild Chronic HypertensionTorri D. Metz et al. · Obstetrics and Gynecology · 2024 · PubMed · cited 7
- Combined Treatment of Uterine Leiomyosarcoma with Gamma Secretase Inhibitor MK-0752 and Chemotherapeutic Agents Decreases Cellular Invasion and Increases ApoptosisYasmin Abedin et al. · Cancers · 2024 · PubMed · cited 5
- Mean Arterial Pressure and Neonatal Outcomes in Pregnancies Complicated by Mild Chronic HypertensionMatthew D. Moore et al. · Obstetrics and Gynecology · 2024 · PubMed · cited 6
- Prognostic Effect of Mismatch Repair Status in Early-Stage Endometrial Cancer Treated With Adjuvant Radiation: A Multi-institutional AnalysisLara Hathout et al. · International Journal of Radiation Oncology*Biology*Physics · 2024 · PubMed · cited 5
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/rutgers-health-robert-wood-johnson-medical-schoo-mfm"><img src="https://openprograms.org/programs/rutgers-health-robert-wood-johnson-medical-schoo-mfm/badge.svg" alt="Rutgers Health/Robert Wood Johnson Medical School Maternal-Fetal Medicine fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.